Meet an Unreasonable Venture
Epoch Biodesign
Using AI-designed enzymes to enable infinite recycling of mixed plastics and textiles.
Epoch Biodesign develops enzymatic processes to recycle plastic and textile waste, starting with nylon. Using AI-driven synthetic biology and materials science, it breaks plastics down into high-purity chemical building blocks for reuse. Based in London, Epoch operates at lab scale, with a demo facility targeting 150 metric tonnes annually in 2025. Long term, it aims to license and operate its technology globally, driving scalable circularity.
Notable Achievements
- Raised more than $50M from investors including Lowercarbon Capital, Inditex, and Extantia.
- Working with over 30 leading brands to develop and scale circular textile solutions.
- Built a world-class team of 30 biochemists, process engineers, and ML scientists.
Currently Operating in One Region
Get the Unreasonable Newsletter
Get monthly updates on Epoch Biodesign and all of the other ventures working to solve the world's toughest problems.